National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-PLGF monoclonal antibody TB-403
A humanized monoclonal antibody directed against placental growth factor (PLGF) with potential anti-angiogenic and antineoplastic acivities. Anti-PLGF monoclonal antibody TB-403 binds to PLGF, inhibiting the binding of PLGF to the vascular endothelial growth factor receptor, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. PLGF is a protein that belongs to the family of vascular endothelial growth factors (VEGFs). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:anti-placental growth factor monoclonal antibody TB-403
Code name:TB-403



Previous:anti-myeloma cell surface antigen immunoconjugate BT-062, anti-p53 T-cell receptor-transduced peripheral blood lymphocytes, anti-PD-1 human monoclonal antibody MDX-1106, anti-PD-1 monoclonal antibody CT-011, anti-PD-L1 monoclonal antibody MDX-1105
Next:anti-PSCA fully human monoclonal antibody MK4721, anti-thymocyte globulin, antibody-drug conjugate CR011-vcMMAE, antineoplaston A10, antineoplaston AS2-1

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov